Polysulfated Glycosaminoglycan side effects in Warmbloods

37 FDA reports involve Polysulfated Glycosaminoglycan in a Warmblood. These are the problems they describe.

Injection site reaction
16 43%
Swelling
9 24%
Hair coat discolouration
6 16%
Product defect, general
5 14%
Allergic reaction
5 14%
Lethargy
4 11%
Leucopenia
3 8.1%
Lameness
3 8.1%
Diarrhea
3 8.1%
Colic
2 5.4%
Pigmentation disorder
2 5.4%
Localised pain (see other 'socs' for specific pain)
2 5.4%

All reports for Polysulfated Glycosaminoglycan in horses